Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

Sleeve Gastrectomy and Hernia Repair Hold Up Long Term

Sleeve gastrectomy with hiatal hernia repair shows acceptable long-term outcomes, with postoperative reflux symptoms being associated with recurrence and need for reintervention.

Liver Steatosis Common in Women Referred for PMOS

A study of young women referred for PMOS finds high rates of liver steatosis, while commonly used screening tools miss most cases of liver fibrosis.

Menopausal Hormone Therapy Tied to Risk for Eye Misalignment

Menopausal hormone therapy is linked to increased risks for diagnosis of and surgery for strabismus, and researchers detect estrogen receptor alpha in the human eye muscle.

Constipation Common but Rarely New in GLP-1 Users

Constipation is already prevalent in patients with obesity initiating GLP-1 therapy, but only a small proportion develop new symptoms after beginning treatment.

New AI Imaging Detects ‘Striking’ Obesity-Related Neuropathy

Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it may be linked to GLP-1 use.

Safe Antibiotics in Pregnancy and Breastfeeding

A new ENTIS webinar highlights evidence-based antibiotic choices in pregnancy and lactation, including when amoxicillin, fosfomycin, and macrolides can be used safely.

Todays Updates

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

The tool, based on histology only, may help identify patients most likely to benefit from triplet therapy.

Community Oncology Well Suited for Advanced Cancer Patients

Experts tout common characteristics of local physician practices that are beneficial to those with advanced disease.

Todays Updates

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

The tool, based on histology only, may help identify patients most likely to benefit from triplet therapy.

Community Oncology Well Suited for Advanced Cancer Patients

Experts tout common characteristics of local physician practices that are beneficial to those with advanced disease.

Latest News

Sleeve gastrectomy with hiatal hernia repair shows acceptable long-term outcomes, with postoperative reflux symptoms being associated with recurrence and need for reintervention.

A study of young women referred for PMOS finds high rates of liver steatosis, while commonly used screening tools miss most cases of liver fibrosis.

Menopausal hormone therapy is linked to increased risks for diagnosis of and surgery for strabismus, and researchers detect estrogen receptor alpha in the human eye muscle.

Constipation is already prevalent in patients with obesity initiating GLP-1 therapy, but only a small proportion develop new symptoms after beginning treatment.

Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it may be linked to GLP-1 use.

A new ENTIS webinar highlights evidence-based antibiotic choices in pregnancy and lactation, including when amoxicillin, fosfomycin, and macrolides can be used safely.

News All Time

BMI Extremes Tied to Worse Pregnancy Outcomes With ART

BMI appears to have a greater impact on pregnancy continuation than on achieving initial implantation or pregnancy. Study findings suggest promoting proactive BMI optimization before treatment.

India's New Transgender Rules Worry Doctors, Disrupt Care

Mehr Khan, an Indian transgender woman, arrived for a routine hormone therapy appointment only to discover the crucial treatment had been suspended after a recent change in the law.

Kailera Shares Tumble on High Nausea Rates Despite Weight-loss Drug's Success

Kailera Therapeutics' shares dropped 10% on Tuesday after its oral weight-loss drug showed high rates ⁠of nausea and vomiting among participants in a late-stage trial in...

Pharmacist-Led Outreach Improves SGLT2 Inhibitor Uptake

Patients with chronic kidney disease and type 2 diabetes receiving pharmacist-led outreach were nearly twice as likely to start an SGLT2 inhibitor as those receiving usual care.

EMA Fast-tracks Review Of Revolutions' Experimental Pancreatic Cancer Pill

The European Medicines Agency said on Tuesday it has begun a rolling review of Revolution ⁠Medicines' experimental treatment for patients with metastatic pancreatic...

Cortisol Normalises by 4 Weeks After Stopping Contraceptives

Serum corticosteroid-binding globulin and total cortisol levels decrease rapidly and normalise within 4 weeks after the cessation of combined oral contraceptives, a Dutch study shows.

Middle-of-the-Night Eating Skews the Gut’s Circadian Clocks

Off-schedule eating disrupted intestinal circadian clocks in mice, which may help explain digestive and metabolic issues in night-shift workers.

Can Elevated MMP12 Levels Predict Pancreatic Cancer Risk?

Increased MMP12 levels are associated with a higher risk for pancreatic cancer, especially among patients diagnosed within 4 years of blood collection for immune marker analysis, a study reports.

Obesity Drugs Work Best for Youth With Lifestyle Support

The combination of obesity drugs with structured lifestyle programs ranks highest for yielding the greatest weight loss in children and adolescents, a network meta-analysis finds.

The Evolving Role of Non-Oral Contraceptive Strategies in Patient-Centered Care

The Evolving Role of Non-Oral Contraceptive Strategies in Patient-Centered Care

Current Evidence and Clinical Considerations in Non-Oral Contraceptive Care

Current Evidence and Clinical Considerations in Non-Oral Contraceptive Care

Navigating New Guidelines and Evidence in MASH: Noninvasive Assessments and Individualized Care

Navigating New Guidelines and Evidence in MASH: Noninvasive Assessments and Individualized Care

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Unproven Peptides Need More Regulation, AMA Delegates Say

Let's "separate the science from the snake oil," says delegate

Drug Fights GLP-1 Muscle Loss; Unapproved Retatrutide Prescriptions; Protein Swap

News and commentary from the endocrinology world

Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes

Investigational pill was well-tolerated and doesn't come with food or water restrictions

Recommended News For You

Prostate cancer Q&A: Improving detection and reducing overtreatment

"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.

According to a study, there is now a 94 percent survival rate for children with acute lymphatic leukemia.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

ASCO Future Focus: Follicular Lymphoma: Future Focus from the American Society of Clinical Onology

Novel biomarker has potential for predicting and treating skin cancer metastasis

Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.

Recommended Articles For You

Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging 

Neonatal Hematopoietic Transition and Blood Cell Maturation 

Polycythemia Vera: A Historical Perspective and Contemporary Management 

Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib

2.

Study reveals link between new-onset type 2 diabetes and some obesity-related cancers

3.

A specific drug combination is being tested in a clinical trial for the deadly brain cancer glioblastoma.

4.

'Ticking Time Bomb'; Jimmy Carter's Lasting Impact on Cancer; Breast Cancer-CVD Link

5.

Orca-T Approved to Prevent GVHD After Stem Cell Transplant for Blood Cancers

1.

Revolutionizing Cancer Care: The Promise of Early Detection and Biomarkers

2.

Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment

3.

The Benefits and Risks of Thrombolytics: A Comprehensive Guide 

4.

Women's Cancer Survivorship: Emerging Long-Term Health Priorities

5.

Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

2.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V

4.

Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites

5.

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot